NovaBridge Biosciences
NBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $381,601 | $197,712 | $67,230 | $69,271 |
| - Cash | $228,064 | $165,404 | $53,597 | $68,263 |
| + Debt | $3,275 | $3,481 | $3,684 | $3,882 |
| Enterprise Value | $156,812 | $35,789 | $17,317 | $4,890 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$216 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8,773 | -$7,114 | -$5,266 | -$12,098 |
| % Margin | – | – | – | – |
| Net Income | -$6,828 | -$5,504 | -$3,150 | -$9,062 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.068 | -0.068 | -0.28 | -0.11 |
| % Growth | 0% | 75.9% | -154.5% | – |
| Operating Cash Flow | $1,846 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $1,846 | $0 | $0 | $0 |